{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:01Z","timestamp":1787002801906,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41433-026-04324-4","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:00:15Z","timestamp":1775296815000},"page":"950-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macular and retinal manifestations following COVID-19 vaccinations: a 2025 update systematic review and meta-analysis"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-3129","authenticated-orcid":false,"given":"Aishwarya","family":"Rajesh Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida-Maisie","family":"Famiyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afreen","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-4513","authenticated-orcid":false,"given":"Patrick Xiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6224-2273","authenticated-orcid":false,"given":"Nirojini","family":"Sivachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"4324_CR1","doi-asserted-by":"crossref","unstructured":"Elrobaa IH, New KJ. COVID-19: pulmonary and extra pulmonary manifestations. Front Public Health. 2021;9:711616.","DOI":"10.3389\/fpubh.2021.711616"},{"key":"4324_CR2","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00417-022-05953-7","volume":"261","author":"S Yeo","year":"2023","unstructured":"Yeo S, Kim H, Lee J, Yi J, Chung YR. Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review. Graefes Arch Clin Exp Ophthalmol. 2023;261:1793\u2013808.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4324_CR3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.4103\/ijo.IJO_403_21","volume":"69","author":"M Goyal","year":"2021","unstructured":"Goyal M, Murthy SI, Annum S. Retinal manifestations in patients following COVID-19 infection: a consecutive case series. Indian J Ophthalmol. 2021;69:1275\u201382.","journal-title":"Indian J Ophthalmol"},{"key":"4324_CR4","doi-asserted-by":"publisher","first-page":"111507","DOI":"10.1016\/j.exger.2021.111507","volume":"154","author":"M Farshbafnadi","year":"2021","unstructured":"Farshbafnadi M, Kamali Zonouzi S, Sabahi M, Dolatshahi M, Aarabi MH. Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: the role of entangled risk factors. Exp Gerontol. 2021;154:111507.","journal-title":"Exp Gerontol"},{"key":"4324_CR5","doi-asserted-by":"publisher","first-page":"103553","DOI":"10.1016\/j.jddst.2022.103553","volume":"74","author":"B Wilson","year":"2022","unstructured":"Wilson B, Geetha KM. Lipid nanoparticles in the development of mRNA vaccines for COVID-19. J Drug Deliv Sci Technol. 2022;74:103553.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4324_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/09273948.2022.2032198","volume":"30","author":"E Smith","year":"2022","unstructured":"Smith E, Tran T, Gillies A, Yeung S, Ma PE. Multiple evanescent white dot syndrome following COVID-19 mRNA vaccination in two patients. Ocul Immunol Inflamm. 2022;30:1240\u20133.","journal-title":"Ocul Immunol Inflamm"},{"key":"4324_CR7","doi-asserted-by":"crossref","unstructured":"Kaneda Y, Kawasaki C, Namba M, Kaneda U, Ozaki A, Tanimoto T. Optic neuritis after mRNA vaccination against COVID-19: a secondary analysis of post-approval national safety data by the Japanese government. Ann Eye Sci. 2023;8:1\u20134.","DOI":"10.21037\/aes-22-45"},{"key":"4324_CR8","first-page":"173","volume":"118","author":"DS Lee","year":"2022","unstructured":"Lee DS, Kim JW, Lee KL, Jung YJ, Kang HW. Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: a nationwide observational study. J Infect Dis. 2022;118:173.","journal-title":"J Infect Dis"},{"key":"4324_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/vaccines12111264","volume":"12","author":"S Odani","year":"2024","unstructured":"Odani S, Honda H, Tabuchi T. Association of COVID-19 vaccine intake with diagnosis, hospitalization, and oxygenation\/ventilation: a longitudinal analysis, 2021-2022. Japan Vaccine. 2024;12:1264.","journal-title":"Japan Vaccine"},{"key":"4324_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ophtha.2022.10.017","volume":"130","author":"Y Hashimoto","year":"2023","unstructured":"Hashimoto Y, Yamana H, Iwagami M, Ono S, Takeuchi Y, Michihata N, et al. Ocular adverse events after coronavirus disease 2019 mRNA vaccination: matched cohort and self-controlled case series studies using a large database. Ophthalmol. 2023;130:256\u201364.","journal-title":"Ophthalmol"},{"key":"4324_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2021.1976221","volume":"29","author":"XL Ng","year":"2021","unstructured":"Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29:1.","journal-title":"Ocul Immunol Inflamm"},{"key":"4324_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/medicina60020249","volume":"60","author":"EA Hurissi","year":"2024","unstructured":"Hurissi EA, et al. Ocular complications after COVID-19 vaccination: a systematic review. Medicina. 2024;60:249.","journal-title":"Medicina"},{"key":"4324_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/vaccines13070733","volume":"13","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang H, Lv K, Lin X, Chen F, Cao H, et al. Retinal vascular occlusion following COVID-19 vaccination: a comprehensive review of observational study and pathophysiological mechanisms. Vaccines. 2025;13:733.","journal-title":"Vaccines"},{"key":"4324_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/vaccines11081281","volume":"11","author":"HM Leung","year":"2023","unstructured":"Leung HM, Au SCL. Retinal vein occlusion after COVID-19 vaccination\u2014a review. Vaccines. 2023;11:1281.","journal-title":"Vaccines"},{"key":"4324_CR15","unstructured":"World Health Organization. Causality Assessment of an Adverse Event Following Immunization (AEFI) : User Manual for the Revised WHO Classification, 2nd ed., 2019 Update. Geneva, Switzerland: World Health Organization; 2021."},{"key":"4324_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.756633","volume":"9","author":"D Montano","year":"2022","unstructured":"Montano D. Frequency and associations of adverse reactions of COVID-19 vaccines reported to pharmacovigilance systems in the European Union and the United States. Front Public Health. 2022;9:756633.","journal-title":"Front Public Health"},{"key":"4324_CR17","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.vaccine.2024.03.001","volume":"42","author":"M Raethke","year":"2024","unstructured":"Raethke M, van Hunsel F, Luxi N, Lieber T, Bellitto C, Mulder E, et al. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study. Vaccine. 2024;42:2357\u201369.","journal-title":"Vaccine"},{"key":"4324_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"4","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxyman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;4:383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"4324_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139.","journal-title":"Contemp Clin Trials"},{"key":"4324_CR20","doi-asserted-by":"crossref","unstructured":"Ouranos K, Avila DV, Mylona EK, Vassilopoulos A, Vassilopoulos S, Shehadeh F, et al. Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: a systematic review and meta-analysis. PLoS One. 2024;19: e0306548 .","DOI":"10.1371\/journal.pone.0306548"},{"key":"4324_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","volume":"135","author":"S Greenland","year":"1992","unstructured":"Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301\u20139.","journal-title":"Am J Epidemiol"},{"key":"4324_CR22","doi-asserted-by":"publisher","first-page":"441EP","DOI":"10.1001\/jamaophthalmol.2023.0610","volume":"141","author":"I Dorney","year":"2023","unstructured":"Dorney I, Shaia J, Kaelber DC, Talcott KE, Singh RP. Risk of new retinal vascular occlusion after mRNA COVID-19 vaccination within aggregated electronic health record data. JAMA Ophthalmol. 2023;141:441EP\u2013447.","journal-title":"JAMA Ophthalmol"},{"key":"4324_CR23","unstructured":"Coronavirus (COVID-19) vaccinations - our world in data. 2025. https:\/\/ourworldindata.org\/covid-vaccinations."},{"key":"4324_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1434181","volume":"15","author":"D Mohammadi","year":"2024","unstructured":"Mohammadi D, Ghasemi M, Manouchehrian N, Zafarmand M, Akbari M, Boroumand AB. COVID-19 vaccines: current and future challenges. Front Pharmacol. 2024;15:1434181.","journal-title":"Front Pharmacol"},{"key":"4324_CR25","first-page":"1","volume":"6","author":"SA Mendon\u00e7a","year":"2021","unstructured":"Mendon\u00e7a SA, Lorincz R, Boucher P, Curiel DT. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. Vaccine. 2021;6:1\u201314.","journal-title":"Vaccine"},{"key":"4324_CR26","unstructured":"Krellenstein J, Wilkinson G, Osmundson J, Keshanjee S, Rasmussen AL, El-Sadr W. 22 Billion in the Hole: Omicron\u2019s Implications for Global mRNA Vaccine Needs in 2022. Brooklyn, NY: Prep4All; 2022."},{"key":"4324_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","volume":"7","author":"Y Li","year":"2021","unstructured":"Li Y, Tenchov R, Smoot J, Liu C, Watkins S, Zhou Q. A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Cent Sci. 2021;7:512.","journal-title":"ACS Cent Sci"},{"key":"4324_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14760584.2023.2156861","volume":"22","author":"C Sandoval","year":"2023","unstructured":"Sandoval C, Guerrero D, Munoz J, Godoy K, Souza-Mello V, Farias J. Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review. Expert Rev Vaccines. 2023;22:35\u201353.","journal-title":"Expert Rev Vaccines"},{"key":"4324_CR29","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.vaccine.2023.12.031","volume":"42","author":"ML King","year":"2024","unstructured":"King ML. How manufacturing won or lost the COVID-19 vaccine race. Vaccine. 2024;42:1004\u201312.","journal-title":"Vaccine"},{"key":"4324_CR30","doi-asserted-by":"crossref","unstructured":"Pelle MC, Provenzano M, Zaffina I, Pujia R, Giofre F & Luca S, et al. Endothelial dysfunction in COVID-19: potential mechanisms and possible therapeutic options. Life. 2022;12:1605.","DOI":"10.3390\/life12101605"},{"key":"4324_CR31","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/09273948.2022.2094811","volume":"31","author":"A Takacs","year":"2023","unstructured":"Takacs A, Ecsedy M, Nagy ZZ. Possible COVID-19 MRNA vaccine-induced case of unilateral central retinal vein occlusion. Ocul Immunol Inflamm. 2023;31:1145\u201350.","journal-title":"Ocul Immunol Inflamm"},{"key":"4324_CR32","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738\u201342.","journal-title":"J Thromb Haemost"},{"key":"4324_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.avsg.2022.05.001","volume":"84","author":"A Mani","year":"2022","unstructured":"Mani A, Ojha V. Thromboembolism after COVID-19 vaccination: a systematic review of such events in 286 patients. Ann Vasc Surg. 2022;84:12\u201320.e1.","journal-title":"Ann Vasc Surg"},{"key":"4324_CR34","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/jcm11040948","volume":"11","author":"MG Abrignani","year":"2022","unstructured":"Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente A, et al. COVID-19, vaccines, and thrombotic events: a narrative review. J Clin Med. 2022;11:948.","journal-title":"J Clin Med"},{"key":"4324_CR35","first-page":"1","volume":"8","author":"JX Li","year":"2023","unstructured":"Li JX, Wang YH, Bair H, Hsu SB, Chen C, Wei JCC, et al. Risk assessment of retinal vascular occlusion after COVID-19 vaccination. Vaccine. 2023;8:1\u201310.","journal-title":"Vaccine"},{"key":"4324_CR36","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","volume":"42","author":"K Faksova","year":"2024","unstructured":"Faksova K, Walsh D, Jiang Y, Griffin J, Philips A, Gentile A, et al. COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 2024;42:2200\u201311.","journal-title":"Vaccine"},{"key":"4324_CR37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/postgradmedj-2021-140654","volume":"98","author":"AI Francis","year":"2022","unstructured":"Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J. 2022;98:389\u201394.","journal-title":"Postgrad Med J"},{"key":"4324_CR38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","volume":"28","author":"IP Trougakos","year":"2022","unstructured":"Trougakos IP, Terpos E, Alexopopulos H, Politou M, Paraskevis D, Scorilas A, et al. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol Med. 2022;28:542.","journal-title":"Trends Mol Med"},{"key":"4324_CR39","first-page":"1","volume":"15","author":"S Kim","year":"2024","unstructured":"Kim S, Jeon JH, Kim M, Lee Y, Hwang YH, Park M, et al. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-\u03b2 at the injection site. Nat Commun. 2024;15:1\u201315.","journal-title":"Nat Commun"},{"key":"4324_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccep.2021.10.003","volume":"14","author":"MP Canale","year":"2021","unstructured":"Canale MP, Menghini R, Martelli E, Federici M. COVID-19\u2013associated endothelial dysfunction and microvascular injury: From pathophysiology to clinical manifestations. Card Electrophysiol Clin. 2021;14:21.","journal-title":"Card Electrophysiol Clin"},{"key":"4324_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8671713","volume":"2021","author":"A Fodor","year":"2021","unstructured":"Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, et al. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19\u2014mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713.","journal-title":"Oxid Med Cell Longev"},{"key":"4324_CR42","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.3390\/biomedicines11102813","volume":"11","author":"M Sekulovski","year":"2023","unstructured":"Sekulovski M, Mileva N, Vasilev GV, Miteva D, Gulinac M, Preshevska-Sekulovska M, et al. Blood coagulation and thrombotic disorders following SARS-CoV-2 infection and COVID-19 vaccination. Biomedicines. 2023;11:2813.","journal-title":"Biomedicines"},{"key":"4324_CR43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/vaccines10020342","volume":"10","author":"AA Haseeb","year":"2022","unstructured":"Haseeb AA, Solyman O, Abushanab MM, Obaia ASA, Elhusseiny AM. Ocular complications following vaccination for COVID-19: a one-year retrospective. Vaccine. 2022;10:342.","journal-title":"Vaccine"},{"key":"4324_CR44","doi-asserted-by":"crossref","unstructured":"Kyriakidis NC, L\u00f3pez-Cort\u00e9s A, Gonz\u00e1lez EV, Grimaldos AB, Prado EO. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. Vaccine. 2021;6:28.","DOI":"10.1038\/s41541-021-00292-w"},{"key":"4324_CR45","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/vaccines11101626","volume":"11","author":"Y Zou","year":"2023","unstructured":"Zou Y, Kamoi K, Zong Y, Zhang J, Yang M, Ohno-Matsui K. Ocular inflammation post-vaccination. Vaccine. 2023;11:1626.","journal-title":"Vaccine"},{"key":"4324_CR46","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.18240\/ijo.2023.10.25","volume":"16","author":"L Sejournet","year":"2023","unstructured":"Sejournet L, Kodjikian L, Rezkallah A, Denis P, Mathis T, Loria O. Multiple evanescent white dot syndrome relapse following BNT162b2 mRNA COVID-19 vaccination. Int J Ophthalmol. 2023;16:1724.","journal-title":"Int J Ophthalmol"},{"key":"4324_CR47","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/vaccines12101183","volume":"12","author":"M Caldarelli","year":"2024","unstructured":"Caldarelli M, Rio P, Giambra V, Gasbarrini A, Gambassi G, Cianci R. ASIA syndrome: State-of-the-art and future perspectives. Vaccine. 2024;12:1183.","journal-title":"Vaccine"},{"key":"4324_CR48","doi-asserted-by":"crossref","unstructured":"Zhou L, Xu Z, Guerra J, Rosenberg AZ, Fenaroli P, Eberhart CG, et al. Expression of the SARS-CoV-2 receptor ACE2 in human retina and diabetes\u2014implications for retinopathy. Invest Ophthalmol Vis Sci. 2021;62:6.","DOI":"10.1167\/iovs.62.7.6"},{"key":"4324_CR49","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1007\/s10792-023-02908-7","volume":"43","author":"IK Karag\u00f6z","year":"2023","unstructured":"Karag\u00f6z IK, Tokuc EO, Karabas L, Ruckert R, Kaya Mucahit, Munk MR. Expression of key SARS-CoV-2 entry molecules in surgically obtained human retinal biopsies. Int Ophthalmol. 2023;43:5055\u201362.","journal-title":"Int Ophthalmol"},{"key":"4324_CR50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.stemcr.2022.02.015","volume":"17","author":"Y Menuchin-Lasowski","year":"2022","unstructured":"Menuchin-Lasowski Y, Schreiber A, Lecanda A, Mecate-Zambrano A, Brunotte L, Psathaki OE, et al. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids. Stem Cell Rep. 2022;17:789\u2013803.","journal-title":"Stem Cell Rep"},{"key":"4324_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-025-01383-0","volume":"15","author":"J Gong","year":"2025","unstructured":"Gong J, Ge L, Zeng Y, Yang C, Luo Y, Kang J, et al. The influence of SARS-CoV-2 spike protein exposure on retinal development in the human retinal organoids. Cell Biosci. 2025;15:1\u201319.","journal-title":"Cell Biosci"},{"key":"4324_CR52","unstructured":"World Health Organization. COVID-19 Epidemiological Update. Geneva, Switzerland: World Health Organization; 2025."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04324-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:02:58Z","timestamp":1778518978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04324-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4324"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04324-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}